Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Paradromics and Neuralink are leading the race in developing advanced brain implants. Reports highlight differences in ...

Telco extends presence in API arena with two products designed to give businesses practical tools to improve customer experience, while laying the foundation for models of innovation and collaboration ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

In the months since that launch, Liquid has expanded LFM2 into a broader product line — adding task-and-domain-specialized ...

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

To be precise, this is a tiny, IP67-rated box powered by batteries, USB-C, or Power over Ethernet, and it's built around the ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.